Vaccine
Merck Announces Positive Topline Results from Two Phase 3 Adult Studies Evaluating Pneumococcal Conjugate Vaccine
Merck & Co.
PA1299Sep 11, 2020
M&A
TriRx Pharmaceutical Services Acquires MSD Animal Health Manufacturing Site located in Segre-en Anjou Bleu, France Including Long-term Supply Agreement
TriRx Pharmaceutical Services
PR-M09-20-NI-01Sep 01, 2020
Collaboration
Merck and IRBM Announce Pioneering Collaboration to Advance Peptide Therapeutics
IRBM
PR-M07-20-NI-33Jul 23, 2020
M&A
Merck to Acquire Themis
Merck & Co.
PR-M05-20-NI-035May 26, 2020
COVID-19 Vaccine
IAVI and Merck Collaborate to Develop Vaccine Against SARS-CoV-2
Merck & Co.
PR-M05-20-NI-036May 26, 2020
Emergency Response
Merck to Donate 300,000 Masks to New Jersey for COVID-19 Emergency Response
Merck & Co.
PR-M04-20-NI-008Apr 07, 2020
Medical Professionals Across Merck, Pfizer, and Eli Lilly Volunteer Amid COVID-19 Pandemic
Eli Lilly and Company
PR-M04-20-NI-004 Apr 02, 2020
3D Printing
Merck KGaA, Darmstadt, Germany and AMCM / EOS Cooperate in 3D Printing of Tablets
MilliporeSigma
PR-M02-20-NI-042Feb 27, 2020
M&A
Merck to Acquire ArQule, Advancing Leadership in Oncology
Merck & Co.
PR-M12-19-NI-017Dec 12, 2019
Vaccine Approval
Merck’s ERVEBO® [Ebola Zaire Vaccine (rVSVΔG-ZEBOV-GP) live] Granted Conditional Approval in the European Union
Merck & Co.
PR-M11-19-NI-011Nov 13, 2019
FDA Approval
U.S. FDA Approved New Antibacterial for Urinary Tract and Abdominal Infections
Pharma's Almanac
PAO-M08-19-NI-015Aug 07, 2019
Vaccine
CDC Advisory Recommends Vaccination of Adults Ages 27-45 with GARDASIL®9 & Harmonization of Catch-up Vaccination for Males and Females Through Age 26
Merck & Co.
PR-M07-19-NI-004Jul 01, 2019
Track and Trace
IBM, KPMG, Merck and Walmart to Collaborate as Part of FDA’s Program to Evaluate the Use of Blockchain to Protect Pharmaceutical Product Integrity
Merck & Co.
PR-M06-19-NI-021Jun 17, 2019
M&A
Merck to Acquire Peloton Therapeutics, Bolstering Oncology Pipeline
Merck & Co.
PR-M05-19-NI-067May 23, 2019
Restructuring
Merck Undergoes Restructuring
Nice Insight
PAO-M05-19-NI-009May 10, 2019
Announcement
Merck KGaA, Darmstadt, Germany, and Pfizer Announce Discontinuation of Phase III JAVELIN Ovarian PARP 100 Trial in Previously Untreated Advanced Ovarian Cancer
MilliporeSigma
PR-M03-19-NI-062Mar 22, 2019
Accelerated Approval
Merck’s Keytruda to Get Accelerated FDA Evaluation for Treatment of Head and Neck Cancer
Pharma's Almanac
PAO-M02-19-NI-015Feb 19, 2019
Biosimilars
U.S. Department of Veterans Affairs Signs Contract with Merck for its Remicade Biosimilar
Nice Insight
PAO-M10-18-NI-010Oct 12, 2018
FDA Approval
Eisai And Merck Announce FDA Approval Of LENVIMA® (lenvatinib) Capsules For First-line Treatment Of Unresectable Hepatocellular Carcinoma (HCC)
Eisai
PR-M09-18-NI-070Sep 24, 2018
FDA Approval
Merck’s HIV-1 Drugs Delstrigo and Pifeltro Get FDA Approval
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M09-18-NI-003Sep 06, 2018